Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Glioma 1Glioblastoma 1Breast Neoplasms 1

Interventions

Specimen Handling 74Magnetic Resonance Spectroscopy 73Cyclophosphamide 69pembrolizumab 57Nivolumab 49Radiotherapy 48fludarabine 41Cisplatin 39Standard of Care 34Carboplatin 33Biopsy 33Bevacizumab 29Dexamethasone 28Rituximab 25Radiation 25Temozolomide 24Surveys and Questionnaires 24Radiosurgery 24Practice Guidelines as Topic 24Gemcitabine 24Doxorubicin 24Blood Specimen Collection 24venetoclax 23Cytarabine 23fludarabine phosphate 22Paclitaxel 21atezolizumab 20Ipilimumab 20Interviews as Topic 19Fluorouracil 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × 4-amino-4'-hydroxylaminodiphenylsulfone × 30 days × Clear all
NCT03975959 2026-06-04

PROMESSE

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Completed
426 enrolled
BreastCNS

Breast Neoplasms, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡